Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US FDA consults on medical device user fee programme

This article was originally published in RAJ Devices

Executive Summary

The US Food and Drug Administration is planning to hold a public meeting on 14 September to gather input on how its next medical device user fee programme should be framed1. The current legislative authority for the programme ends in September 2012 and new legislation will be required for the FDA to be able to continue collecting user fees from medical device companies.

Advertisement
Advertisement
UsernamePublicRestriction

Register

SC096244

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel